Related Experiment Video
Updated: May 20, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
Functional characterization of cancer-associated Gab1 mutations
C Ortiz-Padilla1, D Gallego-Ortega, B C Browne
1Cancer Research Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
Two breast cancer mutations in Gab1 (Grb2-associated binder 1) promote aberrant cell growth and morphology. The T387N mutation disrupts negative feedback, suggesting Gab1 signaling is a target in cancer progression.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Grb2-associated binder 1 (Gab1) is a docking protein involved in signal transduction from receptor tyrosine kinases like Met and EGFR.
- While Gab2 is linked to cancer, Gab1's role has been less defined.
- Two Gab1 mutations, Y83C and T387N, were identified in breast cancer screens.
Purpose of the Study:
- To functionally characterize the identified Gab1 Y83C and T387N mutants.
- To investigate the impact of these mutations on mammary epithelial cell phenotype, proliferation, and signaling.
- To elucidate the mechanism by which these mutations contribute to cancer progression.
Main Methods:
- Overexpression of wild-type Gab1 and Gab1 mutants (Y83C, T387N) in MCF-10A and HC11 mammary epithelial cells.
- Phenotypic analysis, monolayer and Matrigel culture assays.
- Assessment of Erk activation and Gab1 phosphorylation sites via mass spectrometry.
- Analysis of public cancer mutation databases.
Main Results:
- Gab1 mutants induced a fibroblastic phenotype and EGF-independent proliferation.
- Mutant Gab1 expression enhanced aberrant acini formation and branching morphogenesis in Matrigel.
- Mutants modestly increased Erk activation.
- T387 phosphorylation was detected and modulated by EGF/HGF, suggesting T387N disrupts negative feedback.
Conclusions:
- Aberrant Gab1 signaling, driven by mutations like T387N, directly contributes to breast cancer progression.
- Negative feedback sites in docking proteins represent potential targets for oncogenic mutations.
- Gab1 mutations can alter cell morphology and promote uncontrolled proliferation and aberrant tissue architecture.
More Related Videos
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

